Verallia : With continued highly satisfactory results, a shareholder change looks increasingly on the cards

Publication date: 09/08/2018 - Writing date: 09/08/2018 - - - - - - - - - - - - - - - - - - - - - - Following the release of topflight H1 2018 results, featuring a marked improvement in margins and further deleveraging, and the refinancing operations completed in June 2018 which saw the repayment of the 5.125% 2022 secured and 7.250% 2023 unsecured notes in early August 2018, we shall discuss a potential exit of Verallia shareholders in the near term and its impact on the remaining ...

ODDO : German Investment Seminar in NYC – Feedback from second day of meetings

We are hosting our 27th German Investment Seminar in New York from 13 to 15 January 2025. In total, 66 companies are participating. Below, we provide some of our initial feedback on the companies, which were present on day two. Among these companies which were presented during the second day, we notably highlight positive feedback on Adidas, Daimler Truck, Evonik, Fuchs, Hensoldt, Jungheinrich, Lanxess, Qiagen, Renk, Rheinmetall and Siemens Healthineers.

bioMerieux : Acquisition and update of the installed base in Q4. Outperform rating (vs Neutral) and target price of € 132 (vs € 113)

bioMérieux : Acquisition et update de la base installée au T4. Opinion Surperformance (vs Neutre) et OC à 132 € (vs 113 €)